Regeneron Pharmaceuticals Profit Expected to Slip

Despite an expected dip in profit, analysts are generally optimistic about Regeneron Pharmaceuticals as it prepares to reports its first-quarter earnings on Thursday, May 8, 2014. The consensus earnings per share estimate is 99 cents per share.Over the past month, the consensus estimate has jumped from 98 cents, but it's below